{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:34:50Z","timestamp":1789014890219,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10517-026-06645-6","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:55:05Z","timestamp":1777053305000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Possible Ways of Reducing Adverse Events Associated with mRNA Vaccines Encapsulated in Lipid Nanoparticles"],"prefix":"10.1007","volume":"180","author":[{"given":"L. A.","family":"Kisakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Ilyicheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Rudometov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"4","key":"6645_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines \u2013 a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261-79. https:\/\/doi.org\/10.1038\/nrd.2017.243","journal-title":"Nat Rev Drug Discov."},{"issue":"27","key":"6645_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-15. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N Engl J Med."},{"issue":"1","key":"6645_CR3","doi-asserted-by":"publisher","first-page":"2477384","DOI":"10.1080\/21645515.2025.2477384","volume":"21","author":"B Wang","year":"2025","unstructured":"Wang B, Yin Q, Yi L, et al. Lyophilized monkeypox mRNA lipid nanoparticle vaccines with long-term stability and robust immune responses in mice. Hum Vaccin Immunother. 2025;21(1):2477384. https:\/\/doi.org\/10.1080\/21645515.2025.2477384","journal-title":"Hum Vaccin Immunother."},{"key":"6645_CR4","doi-asserted-by":"publisher","unstructured":"Zorina VN. The molecular mimicry and COVID-19. Infekci\u00e2 i Immunitet. 2023;13(5):841-52. (In Russ.) https:\/\/doi.org\/10.15789\/2220-7619-TMM-8878","DOI":"10.15789\/2220-7619-TMM-8878"},{"key":"6645_CR5","doi-asserted-by":"publisher","unstructured":"Banerji A, Wickner PG, SaffR, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9(4):1423-37. https:\/\/doi.org\/10.1016\/j.jaip.2020.12.047","DOI":"10.1016\/j.jaip.2020.12.047"},{"issue":"3","key":"6645_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/gt.2017.5","volume":"24","author":"S Guan","year":"2017","unstructured":"Guan S, Rosenecker J. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Ther. 2017;24(3):133-43. https:\/\/doi.org\/10.1038\/gt.2017.5","journal-title":"Gene Ther."},{"key":"6645_CR7","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/ANBR.202100109","volume":"2","author":"L Xu","year":"2022","unstructured":"Xu L, Wang X, Liu Y, et al. Lipid nanoparticles for drug delivery. Adv Nanobiomed Res. 2022;2:2100109. https:\/\/doi.org\/10.1002\/ANBR.202100109","journal-title":"Adv Nanobiomed Res."},{"issue":"1","key":"6645_CR8","doi-asserted-by":"publisher","first-page":"2200071","DOI":"10.1002\/smsc.202200071","volume":"3","author":"K Hashiba","year":"2022","unstructured":"Hashiba K, Sato Y, Taguchi M, et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci. 2022;3(1):2200071. https:\/\/doi.org\/10.1002\/smsc.202200071","journal-title":"Small Sci."},{"key":"6645_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.29011\/2575-789X.0001115","volume":"9","author":"S Rella","year":"2024","unstructured":"Rella S, Brooks BD. Rethinking risk of adverse events in vaccination. J Vaccines Immunol Immunopathol. 2024;9:1115. https:\/\/doi.org\/10.29011\/2575-789X.0001115","journal-title":"J Vaccines Immunol Immunopathol."},{"issue":"17","key":"6645_CR10","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","volume":"31","author":"H Xu","year":"2010","unstructured":"Xu H, Wang KQ, Deng YH, et al. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes. Biomaterials. 2010;31(17):4757-63. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.02.049","journal-title":"Biomaterials."},{"issue":"3","key":"6645_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.807","volume":"11","author":"F Yasmin","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, et al. Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023;11(3):e807. https:\/\/doi.org\/10.1002\/iid3.807","journal-title":"Immun Inflamm Dis."},{"issue":"9","key":"6645_CR12","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","volume":"42","author":"K Faksova","year":"2024","unstructured":"Faksova K, Walsh D, Jiang Y, et al. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024;42(9):2200-11. https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.100","journal-title":"Vaccine."},{"key":"6645_CR13","unstructured":"EudraVigilance \u2013 EUPATI. URL: https:\/\/toolbox.eupati.eu\/resources\/eudravigilance\/?lang=ru"},{"key":"6645_CR14","unstructured":"VAERS. Vaccine Adverse Event Reporting System. URL: https:\/\/vaers.hhs.gov\/about.html"},{"issue":"4","key":"6645_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331-40. https:\/\/doi.org\/10.1001\/jama.2021.24110","journal-title":"JAMA."},{"key":"6645_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.756633","volume":"9","author":"D Montano","year":"2022","unstructured":"Montano D. Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States. Front Public Health. 2022;9:756633. https:\/\/doi.org\/10.3389\/fpubh.2021.756633","journal-title":"Front Public Health."},{"issue":"4","key":"6645_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/vaccines12040409","volume":"12","author":"A Altay Benetti","year":"2024","unstructured":"Altay Benetti A, Tan EYZ, Chang ZW, et al. Design and characterization of a new formulation for the deli very of COVID-19-mRNA vaccine to the nasal mucosa. Vaccines (Basel). 2024;12(4):409. https:\/\/doi.org\/10.3390\/vaccines12040409","journal-title":"Vaccines (Basel)."},{"key":"6645_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bioactmat.2024.05.012","volume":"38","author":"SH Bae","year":"2024","unstructured":"Bae SH, Yoo S, Lee J, et al. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety. Bioact Mater. 2024;38:486-98. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.012","journal-title":"Bioact Mater."},{"key":"6645_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jconrel.2022.11.037","volume":"353","author":"AJ Da Silva Sanchez","year":"2023","unstructured":"Da Silva Sanchez AJ, Zhao K, Huayamares SG, et al. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery. J Control Release. 2023;353:270-7. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.037","journal-title":"J Control Release."},{"issue":"11","key":"6645_CR20","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","volume":"3","author":"SS Nogueira","year":"2020","unstructured":"Nogueira SS, Schlegel A, Maxeiner K, et al. Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery. ACS Appl Nano Mater. 2020;3(11):10634-45. https:\/\/doi.org\/10.1021\/acsanm.0c01834","journal-title":"ACS Appl Nano Mater."},{"issue":"4","key":"6645_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L, et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2020;15(4):313-20. https:\/\/doi.org\/10.1038\/s41565-020-0669-6","journal-title":"Nat Nanotechnol."},{"issue":"35","key":"6645_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202313791","volume":"36","author":"A Vaidya","year":"2024","unstructured":"Vaidya A, Moore S, Chatterjee S, et al. Expanding RNAi to kidneys, lungs, and spleen via Selective ORgan Targeting (SORT) siRNA lipid nanoparticles. Adv Mater. 2024;36(35):e2313791. https:\/\/doi.org\/10.1002\/adma.202313791","journal-title":"Adv Mater."},{"issue":"7","key":"6645_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron J, Querbes W, Zeigerer A, et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol. 2013;31(7):638-46. https:\/\/doi.org\/10.1038\/nbt.2612","journal-title":"Nat Biotechnol."},{"issue":"11","key":"6645_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Kon E, Sharma P, et al. Endosomal escape: A bottleneck for LNP-mediated therapeutics. Proc Natl Acad Sci USA. 2024;121(11):e2307800120. https:\/\/doi.org\/10.1073\/pnas.2307800120","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"6645_CR25","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Hu Y, Li A, et al. Payload distribution and capacity of mRNA lipid nanoparticles. Nat Commun. 2022;13(1):5561. https:\/\/doi.org\/10.1038\/s41467-022-33157-4","journal-title":"Nat Commun."},{"key":"6645_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101730","volume":"48","author":"S Mao","year":"2023","unstructured":"Mao S, Li S, Zhang Y, et al. A highly efficient needlefree-injection delivery system for mRNA-LNP vaccination against SARS-CoV-2. Nano Today. 2023;48:101730. https:\/\/doi.org\/10.1016\/j.nantod.2022.101730","journal-title":"Nano Today."},{"key":"6645_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120598","volume":"602","author":"R Wang","year":"2021","unstructured":"Wang R, Bian Q, Xu Y, et al. Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. Int J Pharm. 2021;602:120598. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120598","journal-title":"Int J Pharm."},{"issue":"12","key":"6645_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1348-0421.2011.00389.x","volume":"55","author":"Y Omori-Urabe","year":"2011","unstructured":"Omori-Urabe Y, Yoshii K, Ikawa-Yoshida A, et al. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice. Microbiol Immunol. 2011;55(12):893-7. https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00389.x","journal-title":"Microbiol Immunol."},{"issue":"1","key":"6645_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12889-020-10041-8","volume":"21","author":"UF Bullo","year":"2021","unstructured":"Bullo UF, Mehraj J, Raza SM, et al. An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan. BMC Public Health. 2021;21(1):44. https:\/\/doi.org\/10.1186\/s12889-020-10041-8","journal-title":"BMC Public Health."},{"issue":"5","key":"6645_CR30","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.ymthe.2024.03.022","volume":"32","author":"S Abbasi","year":"2024","unstructured":"Abbasi S, Matsui-Masai M, Yasui F, et al. Carrierfree mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity. Mol Ther. 2024;32(5):1266-83. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.022","journal-title":"Mol Ther."},{"issue":"6","key":"6645_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s10517-024-06107-x","volume":"176","author":"DN Kisakov","year":"2024","unstructured":"Kisakov DN, Kisakova LA, Sharabrin SV, et al. Delivery of experimental mRNA vaccine encoding the RBD of SARS-CoV-2 by jet injection. Bull Exp Biol Med. 2024;176(6):776-80. https:\/\/doi.org\/10.1007\/s10517-024-06107-x","journal-title":"Bull Exp Biol Med."},{"issue":"1","key":"6645_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ncrna.2022.09.011","volume":"8","author":"A Dawoud","year":"2022","unstructured":"Dawoud A, Ihab Zakaria Z, Hisham Rashwan H, et al. Circular RNAs: New layer of complexity evading breast cancer heterogeneity. Noncoding RNA Res. 2022;8(1):60-74. https:\/\/doi.org\/10.1016\/j.ncrna.2022.09.011","journal-title":"Noncoding RNA Res."},{"issue":"1","key":"6645_CR33","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9(1):2629. https:\/\/doi.org\/10.1038\/s41467-018-05096-6","journal-title":"Nat Commun."},{"key":"6645_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","volume":"196","author":"P Obi","year":"2021","unstructured":"Obi P, Chen YG. The design and synthesis of circular RNAs. Methods. 2021;196:85-103. https:\/\/doi.org\/10.1016\/j.ymeth.2021.02.020","journal-title":"Methods."},{"issue":"3","key":"6645_CR35","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms24032700","volume":"24","author":"V Gote","year":"2023","unstructured":"Gote V, Bolla PK, Kommineni N, et al. Comprehensive review of mRNA vaccines. Int J Mol Sci. 2023;24(3):2700. https:\/\/doi.org\/10.3390\/ijms24032700","journal-title":"Int J Mol Sci."},{"issue":"4","key":"6645_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/v17040566","volume":"17","author":"T Vallet","year":"2025","unstructured":"Vallet T, Vignuzzi M. Self-amplifying RNA: Advantages and challenges of a versatile platform for vaccine development. Viruses. 2025;17(4):566. https:\/\/doi.org\/10.3390\/v17040566","journal-title":"Viruses."},{"issue":"1","key":"6645_CR37","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","volume":"15","author":"NT H\u1ed3","year":"2024","unstructured":"H\u1ed3 NT, Hughes SG, Ta VT, et al. Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials. Nat Commun. 2024;15(1):4081. https:\/\/doi.org\/10.1038\/s41467-024-47905-1","journal-title":"Nat Commun."},{"key":"6645_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2021.08.029","volume":"338","author":"AK Blakney","year":"2021","unstructured":"Blakney AK, McKay PF, Hu K, et al. Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. J Control Release. 2021;338:201-10. https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.029","journal-title":"J Control Release."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:45:16Z","timestamp":1779083116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6645"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06645-6","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}